Press Release:

Broadlane Selects GERMFREE to Provide
Barrier Isolation Chambers to its Customers for Second Year

Download as Printable PDF

DALLAS - September 26, 2005 - Broadlane, the group procurement services company for healthcare, has renewed its contract with GERMFREE for a second year. The agreement makes GERMFREE the exclusive provider to Broadlane customers of barrier isolation chambers for use in the hospital pharmacy.

Through its innovative pre-committed group buy program, Broadlane brings together hospital clinicians interested in voluntarily committing purchases of a specific diagnostic modality to a winning vendor with the most advanced technology, before bidding even begins. This gives suppliers the knowledge that they could receive significant market share in offering competitive bids. For participating hospitals, it assures best technology with the most favorable terms, conditions and pricing for key capital equipment products and guarantees the combined buying power of all participants.

Broadlane invited the five major North American manufacturers of barrier isolators to its facility in Dallas to give presentations to directors of pharmacy and technical advisers of participating hospitals. The committee conducted a live, in-person comprehensive technology evaluation on all vendors. GERMFREE emerged with the best combination of technology and total cost of ownership and was awarded the contract to become the exclusive provider of barrier isolators to Broadlane’s customers.

“Broadlane is committed to enhancing its contracting portfolio to address the rapid developments in the sterile compounding regulatory environment,” said Camber Hayman, director of pharmacy contracting for Broadlane. “Broadlane ensures that its customers have access to key products and services that not only will add to the safety of their employees and patients, but will assist in their compliance with the new standards.”

Cherie Berdovich, director of sales and marketing of GERMFREE said, “Recent shifts in pharmacy regulation, such as USP <797> as well as the imminent threat of future changes, have placed emphasis on patient and operator safety during sterile preparations and the compounding of hazardous drugs. Long the status quo in European pharmacies, barrier isolation technology is emerging in the United States as a safe and cost-efficient alternative to the use of laminar flow hoods inside a clean room. GERMFREE and its customers are committed to maintaining the safest possible hospital environments while always staying ahead of the latest regulatory updates.”

About GERMFREE
Based in Ormond Beach, Fla., GERMFREE specializes in the production of all-stainless steel laminar flow equipment for hospital and pharmacy use. GERMFREE manufactures a full line of barrier isolators as well as horizontal and vertical laminar flow hoods, chemo hoods and compounding safety enclosures. With over 40 years in the industry, GERMFREE has the experience to provide the best protection for patients, personnel and products. For more information contact info@germfree.com, 800-888-5357, or visit www.Germfree.com.

About Broadlane
Broadlane is the group procurement services company for healthcare. Through a comprehensive set of proven procurement processes, Broadlane helps healthcare providers go further to reduce costs and improve financial performance. The company's signature service is group purchasing; its numerous other services include strategic procurement planning, departmental cost management, and labor sourcing and utilization. Broadlane's innovative technology yields data-driven solutions, which are implemented by an expert staff with deep clinical and operational experience.

Broadlane serves thousands of acute care hospitals, sub-acute care facilities and physician practices across the country. The company is headquartered in San Francisco with offices in California, New York, Ohio and Texas.